Quote:
Originally Posted by combustiblefuel
Long story short is drug company rebrands drug under a new name to save fave after devestating losses due to a #### head ceos bad p.r.
|
I think one of us didn't read the article correctly, not sure if it was me or not...
Imprimis has started marketing an alternative for the drug that Turing/Shkreli raised the price on. Unless Imprimis is the same company as Turing and I missed it, it seems to me this is a pretty good development...